Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine IV-PCA for Postoperative Pain
NCT05672225Recruiting
- Sponsor
- Korea University Guro Hospital
- Start
- Feb 2023
- Primary completion
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of dexmedetomidine in postoperative pain (2 arms), sponsored by Korea University Guro Hospital. Primary endpoint: Fentanyl consumption during 24 hours. Started Feb 2023; status: recruiting.
02
Drugs
dexmedetomidine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT05672225.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05672225.